{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["12"],"submitter":["Zhou Y"],"pubmed_abstract":["<h4>Background</h4>CEUS LI-RADS and CT/MRI LI-RADS have been used in clinical practice for several years. However, there is a lack of evidence-based study to compare the proportion of hepatocellular carcinomas (HCCs) in each category and the distribution of HCCs of these two categorization systems.<h4>Purpose</h4>The purpose of this study was to compare the proportion of HCCs between corresponding CEUS LI-RADS and CT/MRI LI-RADS categories and the distribution of HCCs and non-HCC malignancies in each category.<h4>Methods</h4>We searched PubMed, Embase, and Cochrane Central databases from January 2014 to December 2021. The proportion of HCCs and non-HCC malignancies and the corresponding sensitivity, specificity, accuracy, diagnostic odds ratio (DOR), and area under the curve (AUC) of the L"],"journal":["Frontiers in oncology"],"pagination":["873913"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9001845"],"repository":["biostudies-literature"],"pubmed_title":["Risk Stratification and Distribution of Hepatocellular Carcinomas in CEUS and CT/MRI LI-RADS: A Meta-Analysis."],"pmcid":["PMC9001845"],"pubmed_authors":["Jing X","Zhao L","Qin Z","Wang F","Chen Y","Zhou Y","Ding J"],"additional_accession":[]},"is_claimable":false,"name":"Risk Stratification and Distribution of Hepatocellular Carcinomas in CEUS and CT/MRI LI-RADS: A Meta-Analysis.","description":"<h4>Background</h4>CEUS LI-RADS and CT/MRI LI-RADS have been used in clinical practice for several years. However, there is a lack of evidence-based study to compare the proportion of hepatocellular carcinomas (HCCs) in each category and the distribution of HCCs of these two categorization systems.<h4>Purpose</h4>The purpose of this study was to compare the proportion of HCCs between corresponding CEUS LI-RADS and CT/MRI LI-RADS categories and the distribution of HCCs and non-HCC malignancies in each category.<h4>Methods</h4>We searched PubMed, Embase, and Cochrane Central databases from January 2014 to December 2021. The proportion of HCCs and non-HCC malignancies and the corresponding sensitivity, specificity, accuracy, diagnostic odds ratio (DOR), and area under the curve (AUC) of the L","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-22T19:44:50.186Z","creation":"2025-04-06T02:52:41.575Z"},"accession":"S-EPMC9001845","cross_references":{"pubmed":["35425706"],"doi":["10.3389/fonc.2022.873913"]}}